Curious to find out more about the @IMI_ERA4TB project? Download their info brochure and read all about their dedication to combat #TB 👉https://bit.ly/3bma1WO ERA4TB is part of the @AMRAccelerator projects family.
Join our special Stakeholders Association meeting this Thursday 📅 to hear how, for the first time, almost all patients with drug-resistant #tuberculosis will be able to be treated with an all-oral, six-month regimen. Register now: https://tballiance.zoom.us/webinar/register/WN_Tms6Sd6VR8yimO0ow4HpDA
@amr_d2 representation at the 5th @IMI_ERA4TB consortium meeting. Huge thanks to @SynapseManagers for superb organization of the meeting and to @IMI_ERA4TB memebers for two days of intensive networking.
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 853989.
The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Global Alliance for TB Drug Development non profit organisation, Bill & Melinda Gates Foundation and University of Dundee.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.